TY - JOUR
T1 - Follow-up after gastrectomy for cancer
T2 - the Charter Scaligero Consensus Conference
AU - Baiocchi, Gian Luca
AU - D’Ugo, Domenico
AU - Coit, Daniel
AU - Hardwick, Richard
AU - Kassab, Paulo
AU - Nashimoto, Atsushi
AU - Marrelli, Daniele
AU - Allum, William
AU - Berruti, Alfredo
AU - Chandramohan, Servarayan Murugesan
AU - Coburn, Natalie
AU - Gonzàlez-Moreno, Santiago
AU - Hoelscher, Arnulf
AU - Jansen, Edwin
AU - Leja, Marcis
AU - Mariette, Christophe
AU - Meyer, Hans Joachim
AU - Mönig, Stefan
AU - Morgagni, Paolo
AU - Ott, Katia
AU - Preston, Shaun
AU - Rha, Sun Young
AU - Roviello, Franco
AU - Sano, Takeshi
AU - Sasako, Mitsuru
AU - Shimada, Hideaki
AU - Schuhmacher, Cristoph
AU - So Bok-yan, Jimmy
AU - Strong, Vivian
AU - Yoshikawa, Takaki
AU - Terashima, Masanori
AU - Ter-Ovanesov, Michail
AU - Van der Velde, Cornelis
AU - Memo, Maurizio
AU - Castelli, Francesco
AU - Pecorelli, Sergio
AU - Detogni, Claudio
AU - Kodera, Yasuhiro
AU - de Manzoni, Giovanni
N1 - Publisher Copyright:
© 2015, The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Purpose: Presently, there is no scientific evidence supporting a definite role for follow-up after gastrectomy for cancer, and clinical practices are quite different around the globe. The aim of this consensus conference was to present an ideal prototype of follow-up after gastrectomy for cancer, based on shared experiences and taking into account the need to rationalize the diagnostic course without losing the possibility of detecting local recurrence at a potentially curable stage. Methods: On June 19–22, 2013 in Verona (Italy), during the 10th International Gastric Cancer Congress (IGCC) of the International Gastric Cancer Association, a consensus meeting was held, concluding a 6-month, Web-based, consensus conference entitled “Rationale of oncological follow-up after gastrectomy for cancer.” Results: Forty-eight experts, with a geographical distribution reflecting different health cultures worldwide, participated in the consensus conference, and 39 attended the consensus meeting. Six statements were finally approved, displayed in a plenary session and signed by the vast majority of the 10th IGCC participants. These statements are attached as an annex to the Charter Scaligero on Gastric Cancer. Conclusion: After gastrectomy for cancer, oncological follow-up should be offered to patients; it should be tailored to the stage of the disease, mainly based on cross-sectional imaging, and should be discontinued after 5 years.
AB - Purpose: Presently, there is no scientific evidence supporting a definite role for follow-up after gastrectomy for cancer, and clinical practices are quite different around the globe. The aim of this consensus conference was to present an ideal prototype of follow-up after gastrectomy for cancer, based on shared experiences and taking into account the need to rationalize the diagnostic course without losing the possibility of detecting local recurrence at a potentially curable stage. Methods: On June 19–22, 2013 in Verona (Italy), during the 10th International Gastric Cancer Congress (IGCC) of the International Gastric Cancer Association, a consensus meeting was held, concluding a 6-month, Web-based, consensus conference entitled “Rationale of oncological follow-up after gastrectomy for cancer.” Results: Forty-eight experts, with a geographical distribution reflecting different health cultures worldwide, participated in the consensus conference, and 39 attended the consensus meeting. Six statements were finally approved, displayed in a plenary session and signed by the vast majority of the 10th IGCC participants. These statements are attached as an annex to the Charter Scaligero on Gastric Cancer. Conclusion: After gastrectomy for cancer, oncological follow-up should be offered to patients; it should be tailored to the stage of the disease, mainly based on cross-sectional imaging, and should be discontinued after 5 years.
UR - http://www.scopus.com/inward/record.url?scp=84951052940&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951052940&partnerID=8YFLogxK
U2 - 10.1007/s10120-015-0513-0
DO - 10.1007/s10120-015-0513-0
M3 - Review article
C2 - 26140915
AN - SCOPUS:84951052940
SN - 1436-3291
VL - 19
SP - 15
EP - 20
JO - Gastric Cancer
JF - Gastric Cancer
IS - 1
ER -